1
TITLE: Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed
AUTHORS: JOÃO PEDRO FERREIRA ; JOÃO SÉRGIO NEVES; FRANCISCA SARAIVA;
PUBLISHED: 2024, SOURCE: Journal of Cardiac Failure
INDEXED IN: Scopus
2
TITLE: Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved  Full Text
AUTHORS: Rastogi, Tripti; Ferreira, Joao Pedro ; Butler, Javed; Kraus, Bettina Johanna; Mattheus, Michaela; Brueckmann, Martina; Filippatos, Gerasimos; Wanner, Christoph; Pocock, Stuart J.; Packer, Milton; Anker, Stefan D.; Zannad, Faiez;
PUBLISHED: 2024, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE
INDEXED IN: Scopus WOS
3
TITLE: Growth differentiation factor-15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program
AUTHORS: Ferreira, Joao Pedro ; Packer, Milton; Butler, Javed; Filippatos, Gerasimos; Pocock, Stuart J.; Januzzi, James L.; Sattar, Naveed; Maldonado, Sandra Gonzalez; Panova Noeva, Marina; Sumin, Mikhail; Masson, Serge; Anker, Stefan D.; Zannad, Faiez;
PUBLISHED: 2024, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 26, ISSUE: 1
INDEXED IN: Scopus WOS
4
TITLE: Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial  Full Text
AUTHORS: Cruz, Marli; Ferreira, Joao Pedro ; Diaz, Silvia O. O. ; Ferrao, Diana; Ferreira, Ana Isabel; Girerd, Nicolas; Sampaio, Francisco ; Pimenta, Joana ;
PUBLISHED: 2024, SOURCE: CLINICAL RESEARCH IN CARDIOLOGY, VOLUME: 113, ISSUE: 3
INDEXED IN: Scopus WOS
5
TITLE: Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial
AUTHORS: Santos Ferreira, Diogo; Diaz, Silvia O. ; Ferreira, Joao Pedro ; Girerd, Nicolas; Pellicori, Pierpaolo; Mariottoni, Beatrice; Cosmi, Franco; Hazebroek, Mark; Verdonschot, Job A. J.; Cuthbert, Joe; Petutschnigg, Johannes; Heymans, Stephane; Staessen, Jan A.; Pieske, Burkert; Edelmann, Frank; Clark, Andrew L.; Rossignol, Patrick; Fontes Carvalho, Ricardo ; Cleland, John G. F.; Zannad, Faiez;
PUBLISHED: 2024, SOURCE: ESC HEART FAILURE, VOLUME: 11, ISSUE: 1
INDEXED IN: Scopus WOS
6
TITLE: Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure"
AUTHORS: Ferreira, Joao Pedro ; Neves, Joao Sergio ;
PUBLISHED: 2024, SOURCE: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, VOLUME: 109, ISSUE: 2
INDEXED IN: Scopus WOS
7
8
TITLE: A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial  Full Text
AUTHORS: Kobayashi, Masatake; Huttin, Olivier; Ferreira, Joao Pedro ; Duarte, Kevin; Gonzalez, Arantxa; Heymans, Stephane; Verdonschot, Job A. J.; Brunner La Rocca, Hans Peter; Pellicori, Pierpaolo L.; Clark, Andrew; Petutschnigg, Johannes; Edelmann, Frank G.; Cleland, John; Rossignol, Patrick; Zannad, Faiez; Girerd, Nicolas;
PUBLISHED: 2023, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, ISSUE: 8
INDEXED IN: Scopus WOS
9
TITLE: Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
AUTHORS: Packer, Milton; Butler, Javed; Zeller, Cordula; Pocock, Stuart J.; Brueckmann, Martina; Ferreira, Joao Pedro ; Filippatos, Gerasimos; Usman, Muhammad Shariq; Zannad, Faiez; Anker, Stefan D.;
PUBLISHED: 2023, SOURCE: CIRCULATION, VOLUME: 148, ISSUE: 13
INDEXED IN: WOS
10
TITLE: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from the EMPEROR-Preserved trial  Full Text
AUTHORS: Sharma, Abhinav; Ferreira, Joao Pedro ; Zannad, Faiez; Pocock, Stuart J.; Filippatos, Gerasimos; Pfarr, Egon; Petrini, Michaela; Kraus, Bettina J.; Wanner, Christoph; Packer, Milton; Butler, Javed; Anker, Stefan D.;
PUBLISHED: 2023, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, ISSUE: 8
INDEXED IN: Scopus WOS
Page 1 of 32. Total results: 316.